Human medicines European public assessment report (EPAR): Tepezza, teprotumumab, Date of authorisation: 19/06/2025, Revision: 1, Status: Authorised
Human medicines European public assessment report (EPAR): Trabectedin Accord, trabectedin, Date of authorisation: 25/04/2025, Revision: 1, Status: Authorised
Human medicines European public assessment report (EPAR): Bortezomib Accord, bortezomib, Date of authorisation: 20/07/2015, Revision: 17, Status: Authorised
Member states contact points for translations review
2025 European Medicines Agency annual report on independence
List of medicinal products under additional monitoring
List of medicinal products under additional monitoring
Mobile scanning and other technologies in the labelling and/or package leaflet of centrally authorised medicinal products
Request/declaration form for the provision of information via mobile scanning and other technologies in the centralised procedure
Human medicines European public assessment report (EPAR): Stivarga, regorafenib, Date of authorisation: 26/08/2013, Revision: 24, Status: Authorised